COMMUNIQUÉS West-GlobeNewswire

MolMed and AbCheck sign a three-year Master Agreement for the development of new CARs targeting novel tumor antigens
28/06/2018
The collaboration with AbCheck will allow MolMed to enlarge its proprietary CAR pipeline for both liquid and solid malignancies Milan (Italy) and Plzen (Czech Republic), June 28 th 2018 - MolMed S.p.A. (MLMD.MI), a [...]
Abattis Enters Into Definitive Agreement to Launch New Cannabis Lab in Ontario
28/06/2018
VANCOUVER, British Columbia, June 28, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that it has entered into a definitive investment [...]
CORRECTION - Hydropothecary déclare les résultats du troisième trimestre de l’exercice 2018
28/06/2018
GATINEAU, Québec, 28 juin 2018 (GLOBE NEWSWIRE) -- Veuillez noter qu'une correction a été apportée au communiqué de presse diffusé ce 28 juin 2018, à 6 h 30 HAE. Dans le paragraphe sous " À propos de Hexo ", il aurait [...]
Theratechnologies to Announce Financial Results for Second Quarter 2018
28/06/2018
MONTREAL, June 28, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX:TH) ( Theratechnologies ) announced today that it will issue its financial results for the first quarter ended May 31, 2018, on Thursday, July 5, [...]
Theratechnologies annoncera ses résultats du deuxième trimestre de 2018
28/06/2018
MONTRÉAL, 28 juin 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX:TH) a annoncé aujourd’hui qu’elle dévoilerait ses résultats financiers jeudi le 5 juillet 2018 pour l’exercice financier [...]
Cue Biopharma Strengthens Board of Directors with Addition of Fred Driscoll to Chair Audit Committee
28/06/2018
Driscoll Brings More Than 20 Years of Experience in Financial Management of Life Sciences Companies CAMBRIDGE, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ:CUE) a next-generation immunotherapy [...]
Cantabio Announces Publication of Study on Druggability of the Tau protein in ACS Chemical Neuroscience
28/06/2018
Structural biology based evidence shows that native monomeric Tau can be a viable target for drug-like small molecules, despite its heterogeneous structure SUNNYVALE, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Cantabio [...]
RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®
28/06/2018
RedHill has been granted the exclusive right to co-promote Mytesi ® (crofelemer 125 mg delayed-release tablets) in the U.S. to certain gastroenterologists and primary care physicians for the approved indication in [...]
Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study
28/06/2018
BARDA Funded Study Published in the Journal “Burns” SAN DIEGO, June 28, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) announced today the publication of preclinical data from a study using intravenous [...]
Konica Minolta Launches Portable Ultrasound with One-touch Image Optimization for Improved Workflow and Diagnostic Efficiency
28/06/2018
WAYNE, N.J., June 28, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., announces the introduction of the SONIMAGE® MX1 portable ultrasound system, optimized for musculoskeletal (MSK) and orthopedic [...]
BlissCo's International Cannabis Ecosystem Taking Shape -- CFN Media
28/06/2018
SEATTLE, June 28, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
AXIM® Biotechnologies to Present at 28th Annual International Cannabinoid Research Society Symposium in The Netherlands
28/06/2018
NEW YORK, June 28, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (AXIM ® Biotech ) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company will be attending as a [...]
XORTX Reports on Annual Special Meeting and Provides Corporate Update
28/06/2018
CALGARY, Alberta, June 28, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Rafael Pharmaceuticals Receives FDA Orphan Drug Designation for Treatment of Burkitt Lymphoma, and Initiates a Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia
28/06/2018
Newark, NJ, June 28, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has [...]
Devonian Announces the Signing of a Non-Binding Letter of Intent with Folia Biotech to develop FB-631 in cancer immunotherapy
28/06/2018
QUEBEC CITY, Quebec, June 28, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (" Devonian " or the " Corporation ") (TSX VENTURE:GSD) and Folia Biotech inc. (‘‘Folia’’) today announce the signing of a non-binding [...]
Groupe Santé Devonian annonce la signature d’une lettre d’intention non contraignante avec Folia Biotech pour le développement du FB-631 en immunothérapie pour le cancer
28/06/2018
QUÉBEC, Québec, 28 juin 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) a annoncé aujourd'hui la signature d'une lettre d'intention non contraignante (« lettre d [...]
Grandevo® CG and Venerate® CG for Pest Insect and Mite Control Cleared for Use on Cannabis by the Colorado, Oregon, Washington, Nevada, and Alaska Departments of Agriculture
28/06/2018
Grandevo® CG and Venerate® CG Are Effective Tools for Controlling Economically Damaging Mites and Insect Pests DAVIS, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a [...]
Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI® (palonosetron HCI) in the U.S.
28/06/2018
Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI ® (palonosetron HCI) in the U.S. Iselin, NJ, USA, June 28, 2018 – Helsinn Therapeutics (U.S.) Inc., the U.S. subsidiary of Helsinn, a Swiss [...]
Celsion Corporation Announces Strategic Loan Facility
28/06/2018
$10 Million Improvement to the Balance Sheet Provides Additional Seven Months of Operating Runway LAWRENCEVILLE, N.J., June 28, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or “the Company”), [...]

Pages